Agreement and correctness in adjusting antiepileptic drug treatment: A need for rational drug treatment?

Epilepsia

Volumn 40, Issue 6, 1999, Pages 763-768

  Smeets, R ^a   Meinardi, H ^b   Talmon, J ^a   Hasman, A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Agreement; Correctness; Drug treatment; Epilepsy; Review

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CHOICE; DRUG UTILIZATION; EPILEPSY; HUMAN; MEDICAL DECISION MAKING; OBSERVER VARIATION; PHYSICIAN; PRIORITY JOURNAL;

AMBULATORY CARE; ANTICONVULSANTS; ATTITUDE OF HEALTH PERSONNEL; DECISION MAKING; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; HUMANS; MEDICAL AUDIT; MEDICAL RECORDS; NETHERLANDS; NEUROLOGY; OBSERVER VARIATION;

EID: 0032976190     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00776.x     Document Type: Article

References (36)

1. Shorvon SD. The treatment of epilepsy by drugs. In: Hopkins A, ed. Epilepsy. London: Chapman & Hall, 1987:229-82.
2. Richens A, Davidson DLW, Cartlidge NEF, Easter J, and the EPITEG Collaborative Group. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. J Neurol Neurosurg Psychiatry 1994;57:682-7.
3. Lammers MW. Clinimetrics in epileptology. Thesis, Catholic University, Nijmegen, The Netherlands, 1994.
4. Heller AJ, Chesterman P, Elwes RD, et al. Phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 1995;38:45-50.
5. Porter RJ. Epilepsy: 100 elementary principles, 2nd ed. London: Saunders, 1989.
6. Commission on Antiepileptic Drugs, ILAE. Guidelines for therapeutic monitoring on antiepileptic drugs. Epilepsia 1993;34:585-7.
7. Lough M. A protocol for care. Practitioner 1993;237:484-8.
8. Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med 1996; 334:168-75.
9. Rimmer EM, Richens A. Clinical pharmacology and medical treat-ment. In: Laidlaw J, Richens A, Oxley J, eds. A textbook of epilepsy. Edinburgh: Churchill Livingstone, 1988:421-83.
10. Brodie MJ, Treiman D. Modern management of epilepsy. London: Bailliere Tindall, 1996.
11. Shorvon S, Dreifuss F, Fish D, Thomas D. Treatment of epilepsy. Cambridge: Blackwell Science, 1996.
12. McCluggage JR, Rasey HC, Irwin WG, Dowds MF. Anticonvulsant therapy in a general practice population in Northern Ireland. J R Coll Gen Pract 1984;34:24-31.
13. Presley P. An audit of epilepsy in general practice. Practitioner 1989;233:1009-14.
14. Meijer JWA. Knowledge, attitudes and practice in antiepileptic drug monitoring. Acta Neurol Scand 1991;134(suppl 1):1-128.
15. Martin PJ, Millac PAH. Audit of the management of patients with refractory epitepsy. Seizure 1994;3:295-9.
16. Muir TM, Bradley A, Wood SF, Marray GD, Brodie MJ. An audit of treated epilepsy in Glasgow. Seizure 1996;5:41-6.
17. Meinardi H. Epileptology, military art of healing or science. Inaugural address. Catholic University of Nijmegen, February 1985.
18. Smeets R. Decisions and strategies in drug treatment of epilepsy. Thesis, University of Maastricht, Maastricht, The Netherlands, 1996.
19. Duncan JS, Sander JWAS. The Chalfont seizure severity scale. J Neurol Neurosurg Psychiatry 1991;54:873-6.
20. Cramer JA. A clinimetric approach to assessing quality of life in epilepsy. Epilepsia 1993;4(suppl):8-13.
21. Schouten HJA. Statistical measurement of interobserver agreement, analysis of agreements and disagreements between observers. Thesis, Erasmus University, Rotterdam, The Netherlands, 1985.
22. Schouten HJA. Nominal scale agreement among observers. Psychometrika 1986;51:453-66.
23. Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences, 2nd ed. New York: McGraw-Hill, 1988.
24. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
25. Cooper GL, Huitson A. An audit of the management of patients with epilepsy in thirty general practices. J R Coll Physicians Land 1986;36:204-8.
26. Chappel B, Hall WW. Managing epilepsy in general practice: the dissemination and uptake of a free audit package, and collated results from 12 practices in England and Wales. Seizure 1997;6: 9-12.
27. Roberts SJ, Feely M, Bateman DN. Prescribing of anti-epileptic drugs in the northern and Yorkshire region: 1992-1995. Seizure 1998;7:127-32.
28. Elstein AS, Shulman LS, Sprafka SH. Medical problem solving: an analysis of clinical reasoning. Cambridge: Harvard University Press, 1978.
29. Elwes RDC, Chesterman P, Reynolds EH. The prognosis for seizure control in newly diagnosed epilepsy. N Engt J Med 1984;311: 944-7.
30. Beghi E, Tognoni G. Prognosis of epilepsy in newly referred patients: a multicenter prospective study. Epilepsia 1988;29:236-43.
31. van Donselaar C. Idiopathic first seizure in adult life. Thesis, Erasmus University, Rotterdam, The Netherlands, 1990.
32. Collaborative Group for the Study of Epilepsy. Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy. Epilepsia 1992;33:45-51.
33. Collaborative Group for Epidemiology of Epilepsy. Adverse reactions to antiepileptic drugs: a follow-up study of 355 patients with chronic antiepileptic drug treatment. Epilepsia 1988;29:787-93.
34. Keyser A, Hekster Y, Termond E, Schaap M, Rwiza HT. Sideeffects of drugs in epileptic patients. Pharm Weekbl 1990;12:145-50.
35. Wijsman DJP, Hekster YA, Keyser A, Renier WO, Meinardi H. Clinimetrics and epilepsy care. Pharm Weekbl 1991;13:182-8.
36. Friedman CP, Wyatt JC. Evaluation methods in medical informatics. New York: Springer-Verlag, 1997.